专栏manbetx3.0 社会

Navigating Tensions in China's Centralized Drug Procurement

Amidst public concerns over drug efficacy, China's healthcare system faces scrutiny as doctors and regulatory bodies clash over centralized procurement practices. The debate highlights inherent tensions between cost control and quality assurance, underscoring the need for balanced oversight in healthcare policy.
This English translation is AI-generated and provided for reference only.

In response to claims that drugs from centralized procurement are ineffective, such as "blood pressure not lowering" and "anesthetics not working," the National Healthcare Security Administration recently issued a new statement. While it's good to have a response, this one came too quickly and doesn't match the amount of work required. Moreover, it lacks traceable, real-name endorsements, and even the journalist conducting the interview wasn't named. Therefore, further responses to public concerns are indeed necessary.

During the Shanghai Two Sessions, Zheng Minhua, a standing committee member of the Shanghai CPPCC and director of the General Surgery Department at Ruijin Hospital, pointed out in a media interview that while the national drug procurement has achieved significant results, the public, hospitals, and doctors have other feelings. This led to the widely circulated saying, "blood pressure not lowering, anesthetics not working, laxatives not effective." In fact, there are many posts online about the quality of drugs and medical devices, and these are not isolated opinions.

Zheng Minhua, along with 20 Shanghai CPPCC members, jointly submitted a proposal to the Shanghai CPPCC titled "How to Use Effective Drugs in the Context of Centralized Drug Procurement."

您已阅读13%(1283字),剩余87%(8476字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

远观近思

刘远举,重庆人,先学理工科再学manbetx20客户端下载 学,从事过咨询行业,现为自由撰稿人。关注时政、财经、科技,旨在探寻现象背后的事实与公正。文风理性、客观,且用人性的温度替换虚伪的中立。微博ID@刘远举。

相关文章

相关话题

设置字号×
最小
较小
默认
较大
最大
分享×